Herein, we report the improvement of the binding affinity of the mature antibody 11K2 for its target antigen MCP-1 (monocyte chemotactic protein-1), an important therapeutic target in inflammatory diseases such as arteriosclerosis [14], allergy [15], and rheumatoid arthritis [16]. This evidence concerns the gene CCL2 and rheumatoid arthritis.